Microbio is committed in the fields of cancer, cardiovascular, immune modulation, and postmenopausal care. The business segments include clinically proven botanical drugs, pharmaceutically active ingredients and nutrient supplements. The following nutrition supplements are to launch in the Natural Product Expo West 2003. NK ACTIVATOR™ -is clinical shown to restore natural killer cell activity- 15-LOX INHIBITOR™ -can reduce ``lesion formation`` during atherosclerosis- GSH REGULATOR™ -can reduce glutathione level during uncontrolled cell growth-
Microbio is committed in the fields of cancer, cardiovascular, immune modulation, and postmenopausal care. The business segments include clinically proven botanical drugs, pharmaceutically active ing
Microbio is committed in the fields of cancer, cardiovascular, immune modulation, and postmenopausal care. The business segments include clinically proven botanical drugs, pharmaceutically active ing
Principle of Glutathione (GSH) Most anticancer drugs induce apoptosis directly, thus providing less opportunity for acquired drug resistance, decrease mutagenesis and reduce toxicity. In addition, in
Principle of Glutathione (GSH) Most anticancer drugs induce apoptosis directly, thus providing less opportunity for acquired drug resistance, decrease mutagenesis and reduce toxicity. In addition, in
Principle of Glutathione (GSH) Most anticancer drugs induce apoptosis directly, thus providing less opportunity for acquired drug resistance, decrease mutagenesis and reduce toxicity. In addition, in
Principle of 15-lipoxygenase (15-LOX) In lipid peroxidation, including the oxidative modification of LDL, is recognized as one of the crucial events implicated in the development of atherosclerosis.
Principle of 15-lipoxygenase (15-LOX) In lipid peroxidation, including the oxidative modification of LDL, is recognized as one of the crucial events implicated in the development of atherosclerosis.